Olshavsky et al. [88] reported that cyclin D3 was able to bind to and attenuate androgen receptor activity in prostate cancer cells, where cyclin D3 overexpression inhibited cell proliferation in androgen-dependent cells. The gene discussed is AR; the disease is prostate carcinoma.